• Molecular NameBromodiphenhydramine
  • SynonymAmbodryl Hydrochloride; Amodryl; Bromanautine; Bromazin; Bromazine; Bromazine hydrochloride; Bromdiphenhydramine; Bromdiphenhydramine hydrochloride; Bromdiphenylhydramine Hydrochloride; Bromodiphenhydramine hydrochloride
  • Weight334.257
  • Drugbank_IDDB01237
  • ACS_NO1808-12-4
  • Show 3D model
  • LogP (experiment)4.549
  • LogP (predicted, AB/LogP v2.0)4.59
  • pkaN/A
  • LogD (pH=7, predicted)2.91
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.88
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.1
  • No.of HBond Donors0
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds6
  • TPSA12.47
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antihistamine.
  • Absorption_valueN/A
  • Absorption (description)Well absorbed in the digestive tract.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding96.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmMostly hepatic (CYP-mediated), also renal
  • Half life1 to 4 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySigns of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, swelling of face, lips, tongue, or throat.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A